The results showed that the predictive scores had a significant positive correlation with the immune checkpoints, such as PD1, PD1L2, and was particularly highly correlated with CTLA4, LAG3, and IDO1, suggesting immune regulation plays a key role in the prognosis of breast cancer chemotherapy (31, 32). Here, PDCD1 is linked to breast carcinoma.